Back to Insider Trading View Full Company Profile

TLSI

STRONG

TriSalus Life Sciences, Inc.

CIK: 0001826667

Strong Buy (90% confidence)

Last activity: 2 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $45.15M

Total Cash $20.44M

Total Debt $33.05M

Current Ratio 3.15

Trend Signals

CEO Buy STRONG

CEO buying activity

Feb 23, 2026

CFO Buy STRONG

CFO buying activity

Feb 23, 2026

Insider Roster (9 total, 9 active)

Insider	Buys	Sells	Net Value	Holdings
Stansky Michael P DIRECTOR	2	0	$1.48M	787,132 shares $3.23M
Szela Mary T CEO and President	1	2	$46K	752,987 shares $2.90M
Valle William DIRECTOR	1	0	$125K	30,487 shares $125K
Gordon Gary B. DIRECTOR	1	0	$40K	9,756 shares $40K
Patience David Chief Financial Officer	1	0	$15K	268,657 shares $1.10M
Stevens Jennifer Chief Regulatory Officer	0	3	-$15K	124,110 shares $511K
Marshak Richard Chief Commercial Officer	0	3	-$14K	110,397 shares $455K
Devlin Jodi Chief of Clinical Operations	0	3	-$13K	97,364 shares $401K
Cox Bryan F. Chief of Research	0	3	-$13K	163,415 shares $673K

Recent Transactions

SELL Szela Mary T (CEO and President)

15,944 shares @ $3.85

$61K

Mar 17, 2026

Conviction: | View SEC Filing →

SELL Stevens Jennifer (Chief Regulatory Officer)

774 shares @ $4.12

$3K

Mar 16, 2026

Conviction: | View SEC Filing →

SELL Cox Bryan F. (Chief of Research)

579 shares @ $4.12

$2K

Mar 16, 2026

Conviction: | View SEC Filing →

SELL Marshak Richard (Chief Commercial Officer)

419 shares @ $4.12

$2K

Mar 16, 2026

Conviction: | View SEC Filing →

SELL Devlin Jodi (Chief of Clinical Operations)

273 shares @ $4.12

$1K

Mar 16, 2026

Conviction: | View SEC Filing →

SELL Devlin Jodi (Chief of Clinical Operations)

1,772 shares @ $4.09

$7K

Mar 12, 2026

Conviction: | View SEC Filing →

SELL Marshak Richard (Chief Commercial Officer)

1,589 shares @ $4.09

$6K

Mar 12, 2026

Conviction: | View SEC Filing →

SELL Stevens Jennifer (Chief Regulatory Officer)

1,552 shares @ $4.09

$6K

Mar 12, 2026

Conviction: | View SEC Filing →

SELL Cox Bryan F. (Chief of Research)

1,467 shares @ $4.09

$6K

Mar 12, 2026

Conviction: | View SEC Filing →

SELL Szela Mary T (CEO and President)

4,358 shares @ $4.13

$18K

Mar 11, 2026

Conviction: | View SEC Filing →

SELL Marshak Richard (Chief Commercial Officer)

1,449 shares @ $4.13

$6K

Mar 11, 2026

Conviction: | View SEC Filing →

SELL Stevens Jennifer (Chief Regulatory Officer)

1,204 shares @ $4.13

$5K

Mar 11, 2026

Conviction: | View SEC Filing →

SELL Devlin Jodi (Chief of Clinical Operations)

1,162 shares @ $4.13

$5K

Mar 11, 2026

Conviction: | View SEC Filing →

SELL Cox Bryan F. (Chief of Research)

1,138 shares @ $4.13

$5K

Mar 11, 2026

Conviction: | View SEC Filing →

BUY Stansky Michael P (DIRECTOR)

243,900 shares @ $4.10

$1000K

Feb 23, 2026

Conviction: | View SEC Filing →

BUY Stansky Michael P (DIRECTOR)

117,198 shares @ $4.10

$481K

Feb 23, 2026

Conviction: | View SEC Filing →

BUY Szela Mary T (CEO and President)

30,487 shares @ $4.10

$125K

Feb 23, 2026

Conviction: | View SEC Filing →

BUY Valle William (DIRECTOR)

30,487 shares @ $4.10

$125K

Feb 23, 2026

Conviction: | View SEC Filing →

BUY Gordon Gary B. (DIRECTOR)

9,756 shares @ $4.10

$40K

Feb 23, 2026

Conviction: | View SEC Filing →

BUY Patience David (Chief Financial Officer)

3,657 shares @ $4.10

$15K

Feb 23, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.